A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated Liposomes
Fig 7
Cellular uptake of LP-Compound 2 and Tf-LP-Compound 2.
Flow cytometry after incubation of LP-Compound 2, Tf-LP-Compound 2 and Tf-LP-Compound 2 with holo Tf. Data represent the mean± standard deviation (n = 3)(**p<0.01 vs LP-Compound 2).